Día

noviembre 7, 2012

De Andres F, Vivancos J, Barriga FJ, Díaz F, Izquierdo L, Ortega MA, Castillo L, Ximénez-Carrillo A, Gómez-Escalonilla CI, Torres C, de Salas-Cansado M, Casado MA, Soto J, Gil-Nuñez A

 

Healthcare resource utilization and costs of cardioembolic stroke in the region of Madrid, Spain: preliminary results of CODICE study
15th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Berlin, Germany. 3-7 nov 2012

POSTER

Sánchez-de la Rosa R, Sabater E, Casado MA

 

 

 

Cost analysis of glatiramer acetate versus fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
15th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Berlin, Germany. 3-7 nov 2012

POSTER

Betegon L, Guilloteau I, Martin P, Woolmore A, Oyagüez I

 

 

The relative value of dasatinib versus imatinib as first-line treatment for chronic myeloid leukemiay
15th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Berlin, Germany. 3-7 nov 2012

POSTER

Cobo M, De Castro J, Isla D, Lozano V, Oyagüez I, Castro-Gomez AJ

 

 

Cost-effectiveness of erlotinib as first-line maintenance therapy for advanced non-small-cell lung carcinoma in patients EGFR WT and stable disease after four cycles of chemotherapy
15th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Berlin, Germany. 3-7 nov 2012

POSTER